Literature DB >> 10610713

Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes.

R E Ferrell1, V Conte, E C Lawrence, S M Roth, J M Hagberg, B F Hurley.   

Abstract

Myostatin is a recently identified member of the transforming growth factor-beta family of regulatory factors, also known as growth and differentiation factor 8 (GDF8). The nucleotide sequence of human myostatin was determined in 40 individuals. The invariant promoter contains a consensus MyoD binding site, and the coding sequence contains five missense substitutions in conserved amino acid residues (A55T, K153R, E164K, P198A, and I225T). Two of these, A55T in exon 1 and K153R in exon 2, are polymorphic in the general population with significantly different allele frequencies in Caucasians and African Americans (P < 0.001). Neither of the common polymorphisms had a significant impact on muscle mass response to strength training in either Caucasians or African Americans, although skewed allele frequencies preclude detection of small effects. These allelic variants provide markers for examining association between the myostatin gene and interindividual variation in muscle mass and differences in loss of muscle mass with aging. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10610713     DOI: 10.1006/geno.1999.5984

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  34 in total

1.  Content and localization of myostatin in mouse skeletal muscles during aging, mechanical unloading and reloading.

Authors:  S Kawada; C Tachi; N Ishii
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

2.  The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan.

Authors:  Marta González-Freire; Gabriel Rodríguez-Romo; Catalina Santiago; Natalia Bustamante-Ara; Thomas Yvert; Félix Gómez-Gallego; José A Serra Rexach; Jonatan R Ruiz; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2010-03-23

Review 3.  New fundamental resistance exercise determinants of molecular and cellular muscle adaptations.

Authors:  Marco Toigo; Urs Boutellier
Journal:  Eur J Appl Physiol       Date:  2006-08       Impact factor: 3.078

Review 4.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

Review 5.  Molecular genetic studies of gene identification for sarcopenia.

Authors:  Li-Jun Tan; Shan-Lin Liu; Shu-Feng Lei; Christopher J Papasian; Hong-Wen Deng
Journal:  Hum Genet       Date:  2011-06-26       Impact factor: 4.132

Review 6.  Genes and the ageing muscle: a review on genetic association studies.

Authors:  Nuria Garatachea; Alejandro Lucía
Journal:  Age (Dordr)       Date:  2011-10-27

7.  Is there an optimum endurance polygenic profile?

Authors:  Jonatan R Ruiz; Félix Gómez-Gallego; Catalina Santiago; Marta González-Freire; Zoraida Verde; Carl Foster; Alejandro Lucia
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

8.  Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training.

Authors:  Martine A I Thomis; Wim Huygens; Sofie Heuninckx; Monique Chagnon; Hermine H M Maes; Albrecht L Claessens; Robert Vlietinck; Claude Bouchard; Gaston P Beunen
Journal:  Eur J Appl Physiol       Date:  2004-04-09       Impact factor: 3.078

9.  Association of the K153R polymorphism in the myostatin gene and extreme longevity.

Authors:  Nuria Garatachea; Tomàs Pinós; Yolanda Cámara; Gabriel Rodríguez-Romo; Enzo Emanuele; Giovanni Ricevuti; Letizia Venturini; Alejandro Santos-Lozano; Catalina Santiago-Dorrego; Carmen Fiuza-Luces; Thomas Yvert; Antoni L Andreu; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2013-01-25

10.  The potential role of myostatin and neurotransmission genes in elite sport performances.

Authors:  L Filonzi; N Franchini; M Vaghi; S Chiesa; F Nonnis Marzano
Journal:  J Biosci       Date:  2015-09       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.